GGrantIndex
Sort

89,613 grants matching depression

Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities

$2,918,686
Tallie Z. Z Baram · University Of California-Irvine · P50 · FY2023 · MH

MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS

$2,917,850
Neelum T Aggarwal · Rush University Medical Center · R01 · FY2025 · AG

Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health

$2,917,667
Paige L Williams · Harvard School Of Public Health · R01 · FY2023 · HD

Development of ITI-333, a μ-opioid Receptor Partial Agonist and 5HT2A and D1 Receptor Antagonist, for the Treatment of Opioid Use Disorders

$2,917,074
Gretchen L Snyder · Intra-Cellular Therapies, Inc. · UG3 · FY2021 · DA

Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System

$2,912,944
Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES

Evidence-Informed Mental health Prevention, Assessment, Collaboration, and Treatment in Middle Schools (E-IMPACTS)

$2,910,771
Michael D Lyons · University Of Virginia · RF1 · FY2022 · MH

Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities

$2,909,986
Michele D Kipke · Children'S Hospital Of Los Angeles · U01 · FY2024 · DA

The Care Ecosystem Response to COVID-19: Accelerating Research on Dementia Care that Meets the Needs of Caregivers and Persons with Dementia during COVID-19

$2,908,756
Katherine Laurel Possin · University Of California, San Francisco · R01 · FY2022 · AG

Mild Cognitive Impairment: A Prospective Community Study

$2,906,516
Mary Ganguli · University Of Pittsburgh At Pittsburgh · R37 · FY2022 · AG

Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers

$2,906,437
Leah Helane Rubin · Johns Hopkins University · RF1 · FY2023 · MH

Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)

$2,902,630
Kimford J Meador · Stanford University · U01 · FY2019 · NS

Women HIV Cohort Study: HIV infection and treatment among women of reproductive age

$2,900,790
Maria Luisa Alcaide · University Of Miami School Of Medicine · R01 · FY2019 · HD

Health Disparities in Alzheimer's Disease and Mild Cognitive Impairment among Mexican Americans

$2,899,817
Sid E O'Bryant · University Of North Texas Hlth Sci Ctr · R01 · FY2019 · AG

Using Longitudinal Research to Engage African American and Latinx Sexual- and Gender-Minority Youth in the HIV Prevention and Care Continua and Reduce HIV/AIDS-Related Disparities

$2,898,488
Michele D Kipke · Children'S Hospital Of Los Angeles · U01 · FY2020 · DA

Section on Light and Circadian Rhythms

$2,897,708
Samer Hattar · National Institute Of Mental Health · ZIA · FY2019 · MH

Risk Factors in Childhood-Onset Depression

$2,896,813
Maria Kovacs · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · MH

Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?

$2,884,653
Kyle Matthew Kampman · University Of Pennsylvania · UH3 · FY2023 · DA

Investigating Mechanisms of Intra- and Inter-individual Pain Variability in Patients with Comorbid Chronic Pain and Depression

$2,884,008
Matthew Herbert · University Of California, San Diego · R01 · FY2025 · AR

Pain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patients

$2,883,251
David M Charytan · New York University School Of Medicine · U01 · FY2019 · DK

Los Angeles Latino Eye Study

$2,882,384
University Of Southern California · U10 · FY2004 · EY

Effects of Biomedical Risk Factors on Neuro-cognition Using MRI: Long term follow-up of the Diabetes Control & Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Cohort

$2,882,247
Alan M Jacobson · Nyu Winthrop Hospital · DP3 · FY2017 · DK

Mild Cognitive Impairment: A Prospective Community Study

$2,882,221
Mary Ganguli · University Of Pittsburgh At Pittsburgh · R37 · FY2023 · AG

MACS/WIHS Combined Cohort Study: Brooklyn Clinical Research Site (Bklyn CRS)

$2,882,001
Deborah R. Gustafson · Suny Downstate Medical Center · U01 · FY2025 · HL

Functional and Pharmacological Significance of Receptor Heteromers in the CNS

$2,881,939
Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2025 · DA

EMORY CONTE CENTER FOR NEUROSCIENCE OF MENTAL DISORDERS

$2,881,761
Emory University · P50 · FY2003 · MH